Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro
- PMID: 2228312
- DOI: 10.1002/ijc.2910460515
Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro
Abstract
An extensive series of histological sections reflecting the various states of normal breast tissue, and a range of benign and malignant lesions, were examined for the expression of the p53 protein using a panel of anti-p53 antibodies. In 2 separate series the results of using frozen or methacarn-fixed, paraffin-embedded sections were compared. Strong positive staining for p53 was detected in over 50% of the malignant lesions when frozen sections were used. This number fell to just over 20% when methacarn-fixed sections were examined. In neither series was any p53 staining seen in normal breast or in the benign lesions. Studies by Western blotting on breast cell lines confirmed that this histological signal is due to a pronounced over-expression of the p53 protein. Earlier studies show that this over-expression is associated with mutation of the p53 gene. Mutation of the p53 gene with over-expression of the mutant protein is therefore one of the most frequent specific genetic changes in malignant breast cancer.
Similar articles
-
p53 mutations and expression in breast carcinoma in situ.Am J Pathol. 2000 Jan;156(1):183-91. doi: 10.1016/S0002-9440(10)64718-9. Am J Pathol. 2000. PMID: 10623666 Free PMC article.
-
Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.Br J Cancer. 1995 May;71(5):981-5. doi: 10.1038/bjc.1995.189. Br J Cancer. 1995. PMID: 7734324 Free PMC article.
-
Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.Hum Pathol. 1994 Nov;25(11):1228-33. doi: 10.1016/0046-8177(94)90040-x. Hum Pathol. 1994. PMID: 7959668
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
-
Dysregulation of P53 in breast cancer: Causative factors and treatment strategies.Pathol Res Pract. 2023 Jul;247:154539. doi: 10.1016/j.prp.2023.154539. Epub 2023 May 18. Pathol Res Pract. 2023. PMID: 37257244 Review.
Cited by
-
Biological indices in the assessment of breast cancer.Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221. Clin Mol Pathol. 1995. PMID: 16696013 Free PMC article. No abstract available.
-
Immunohistochemical detection of p53 protein in basal cell skin cancer after microwave-assisted antigen retrieval.J Mol Histol. 2009 Feb;40(1):13-21. doi: 10.1007/s10735-008-9208-8. Epub 2008 Dec 19. J Mol Histol. 2009. PMID: 19096907
-
Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.Virchows Arch. 1994;424(5):491-4. doi: 10.1007/BF00191434. Virchows Arch. 1994. PMID: 7913368
-
A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing.Br J Cancer. 1996 Oct;74(8):1181-7. doi: 10.1038/bjc.1996.514. Br J Cancer. 1996. PMID: 8883402 Free PMC article.
-
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.J Virol. 1996 Feb;70(2):683-8. doi: 10.1128/JVI.70.2.683-688.1996. J Virol. 1996. PMID: 8551603 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous